期刊文献+

血浆α-synuclein水平与帕金森病相关性的Meta分析 被引量:1

A meta-analysis of the relation of plasma α-synuclein levels and Parkinson disease
下载PDF
导出
摘要 目的综合评价人血浆α-synuclein表达水平与帕金森病(PD)的相关性。方法利用Meta分析方法对国内外公开发表以及本课题组尚未发表的关于人血浆α-synuclein水平与帕金森病关系的研究文献进行综合的定量分析。结果共收集到符合纳入标准的文献4篇,累计病例共444例,累计对照共252人;Meta分析结果显示,总体效应检验Z=0.57,P=0.57,标准化均数差(S)为0.26,95%CI=-0.64~1.17,与无效线相交;漏斗图分布呈倒漏斗形,近似对称,发表偏倚较小;敏感性分析结果显示,在排除权重较大和较小的研究后,合并95%CI仍与无效线相交。结论血浆α-synuclein表达水平与帕金森病相关性无统计学意义,但该结论尚需大样本研究证实。 Objective To evaluate comprehensively the association of plasma α-synuclein levels with Parkinson disease(PD).Methods All the published studies on plasma α-synuclein levels and PD for last 20 years were retrieved and standard techniques of meta-analysis combined with the results of these studies were used to produce a more precise estimate.Results Based on the criteria 4 studies were selected with a total of 444 accumulative cases and 252 controls.Meta-analysis results showed that the overall effect value was Z = 0.57(P =0.57) and the standardised mean difference(SMD) value was 0.26(95%CI:-0.64 ~1.17).Inverted funnel plot showed the distribution of a funnel-shaped approximate symmetry.Conclusions Associations of plasma α-synuclein levels with PD has no statistical difference,but there is still need support of a widespread research.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第18期3450-3452,共3页 Chinese Journal of Gerontology
基金 贵州省社会发展科技攻关计划项目〔黔科合SY字(2008)3046号〕
关键词 Α-SYNUCLEIN 帕金森病 META分析 α-synuclein Parkinson disease Meta-analysis
  • 相关文献

参考文献9

  • 1Jesse S, Steinacker P, Lehnert S, et al. Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes : a review[ J 1. CNS Neurosci Ther,2009 ; 15 (2) : 157-82.
  • 2Waragai M,Sekiyama K, Sekigawa A, et al. Alpha-synuclein and D J-1 as potential biological fluid biomarkers for parkinson's disease[J].Int J Mol Sci ,2010 ; 11 ( 11 ) :4257-66.
  • 3Lee PH, Lee G, Park HJ, et al. The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy[J].J Neural Transm,2006 ; 113 ( 10 ) : 1435-9.
  • 4蒋雨平.第11届国际帕金森病和运动障碍大会简讯[J].中国临床神经科学,2007,15(5):454-454. 被引量:2
  • 5Shi M,Zabetian CP, Hancock AM, et al. Significance and confounders of peripheral DJ-1 and alpha-synucIein in Parkinson's disease[J]. Neurosci Lett,2010 ;480( 1 ) :78-82.
  • 6Barbour R, Kling K, Anderson JP, et al. Red blood cells are the major source of alpha-synuclein in blood [ J]. Neurodegener Dis, 2008 ; 5 ( 2 ) : 55 -9.
  • 7Bosco DA, Fowler DM, Zhang Q,et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization[J].Nat Chem Biol,2006;2(5) :249-53.
  • 8Wakabayashi K,Tanji K,Mori F,et al. The Lewy body in Parkinson's disease : molecules implicated in the formation and degradation of alpha-synuclein aggregates [J].Neuropathology,2007 ;27 (5) :494-506.
  • 9El-Agnaf OM, Salem SA, Paleologou KE, et al. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease[J].FASEB J,2006 ;20 (3) :419-25.

共引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部